Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Reports Findings of Commissioned Study Showing a Majority of Affected Americans Approve of Psychedelics as an Alternative Treatment for Select Mental Conditions

The Harris Poll conducted a survey on behalf of Delic Holdings, polling 2,037 adults ages 18 and older, 953 of whom suffer from anxiety/depression/PTSD The survey revealed that 65% of Americans living with anxiety/depression/PTSD believe that psychedelic medicine should be available to patients with treatment-resistant conditions 66%, 62%, and 56% are open to pursuing ketamine, […]

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Marks Significant Milestone in Pursuit of Berubicin Approval for Global GBM Treatment, Raises $11.5 Million from Private Placement

CNS Pharmaceuticals received approval from swissethics for its potentially pivotal study of Berubicin, a novel anthracycline for the treatment of Glioblastoma Multiforme (“GBM”) The approval is the first from a European Ethics Committee The company, which dosed the first patients in its Berubicin program in September, has selected multiple clinical sites across the U.S., Spain, […]

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF): a 2021 Overall Review

FuelPositive has hit multiple milestones throughout 2021, starting with its rebranding in January that ushered it into the world of green hydrogen and ammonia In March, the company acquired the intellectual property for its green ammonia production technology In May, FuelPositive began building its prototype production systems in collaboration with the National Compressed Air in […]

Nemaura Medical Inc. (NASDAQ: NMRD) Commence Rollout of Their Miboko Application; Company Targets Employers & Insurers to Ensure Broad Commercial Distribution

Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices The company recently announced the rollout of its Miboko application by targeting insurers and employers In 2019, over $760 billion was spent on diabetes-related health care, equating to $9,000 per diabetic patient compared to $1,600 for a non-diabetic individual The Miboko […]

Friendable Inc. (FDBL) Discloses Driving Factors Behind Acquisition of Artist Republik and Benefits to Fan Pass Live Artist Platform

Since Summer 2021, Friendable has been searching for the right music distribution platform to pair with its successful flagship offering, Fan Pass Live The acquisition of Artist Republik brings an additional 100,000 artists to the platform and an extensive tech deck that will benefit all parties The Artist Republik acquisition provides independent artists with access […]

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Strengthens its Commitment to the Red Lake Mining District Following Approval of its Exploration Permit for RLX

StraightUp received its early exploration permit that allows it to begin exploration activities on the eastern block of its RLX North property The company will be taking a systematic approach to developing and testing gold targets as it plans to execute its 2022 work programs which will include drilling prospective targets in the summer This […]

Flora Growth Corp. (NASDAQ: FLGC) Kicks off 2022 with Successful First Cannabis Extraction at new Colombia Facility, the Appointment of Tim Leslie as Advisory Board Chairman, and 360 Financial Inc.’s FLGC stock purchase

Flora Growth just announced the production of its first batch of crude oil through its newly constructed facility in Colombia The company has also initiated the EU-GMP certification process that will allow it to target international medical cannabis markets Flora Growth also announced the appointment of Tim Leslie as Chairman of its newly established Advisory […]

Mydecine Innovations Group Inc.’s (NEO: MYCO) (OTC: MYCOF) Plans Program to Provide Resources for Safe, Effective Integration of Psychedelic-Assisted Psychotherapies into Existing Medical Practices

Mydecine plans to launch a program to provide products and services to healthcare professionals, clinics, and hospitals in Canada looking to treat patients through psychedelic-assisted psychotherapy The products and services, which will be available for purchase as a package, include cGMP psilocybin and MDMA, therapy manuals, investigative brochures, protocol training, advisory services, and post-therapy support […]

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Corporate Update Points to Profitability in 2022 and Beyond

In 2021, Delic’s investments and acquisitions allowed for an annualized revenue run-rate of over $9MM Going into the new year, the company looks forward to opening additional ketamine infusion treatment clinics, growing them by 15 within the next 18 months Delic’s growth has been attributed to the strong demand for alternatives to current treatments for […]

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Engages Leading Digital Merchandising Agency to Tap into Ongoing Growth in Snack Food Market by Driving Amazon Sales of Portfolio Products

Eat Well Group has engaged Avenue7Media, a leading digital merchandising agency, to develop the online snacking platform for Eat Well Group portfolio products The platform, scheduled for delivery in Spring 2022, will help Eat Well grow its portfolio investment, brands, and consumer products, through Amazon.com The snacking culture has grown over the last few years, […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

September 22, 2026

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its […]

Rotate your device 90° to view site.